Antizol (PALADIN LABORATORIES (USA) INC)
Welcome to the PulseAid listing for the Antizol drug offered from PALADIN LABORATORIES (USA) INC. This Antidote [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | PALADIN LABORATORIES (USA) INC |
NON-PROPRIETARY NAME: | fomepizole |
SUBSTANCE NAME: | FOMEPIZOLE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Antidote [EPC] |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | INJECTION |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2009-07-31 |
END MARKETING DATE: | 0000-00-00 |
Antizol HUMAN PRESCRIPTION DRUG Details:
Item Description | Antizol from PALADIN LABORATORIES (USA) INC |
LABELER NAME: | PALADIN LABORATORIES (USA) INC |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 1(g/mL) |
START MARKETING DATE: | 2009-07-31 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 46129-200_c045b5a8-b220-4f0a-a831-155b29c19454 |
PRODUCT NDC: | 46129-200 |
APPLICATION NUMBER: | NDA020696 |
Other FOMEPIZOLE Pharmaceutical Manufacturers / Labelers: